Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
Clinical trial NCT01644175 · COMPLETED
Trial details
- NCT number
- NCT01644175
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-04-01
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.